PEPFAR Cuts Drive Sharp Fall In Child HIV Treatment

Original Article by Tamar Kahn | Business Day | 22 July 2026

PEPFAR cuts have been linked to a 45% decline in South African children receiving HIV treatment at US-supported healthcare sites.

PEPFAR Cuts Drive Sharp Fall In Child HIV Treatment

Image | H Ko | Adobe Stock/397482549

The number of South African children receiving HIV treatment at sites supported by the United States government almost halved in the year to September 2025.

New research found that the number of children receiving antiretroviral treatment at sites supported by the US President’s Emergency Plan for AIDS Relief, or PEPFAR, fell by 30,880. This represented a decline of 45%.

South Africa recorded the largest absolute reduction among the countries included in the study. The findings are due to be presented at the 26th International AIDS Conference in Rio de Janeiro.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Aspen Semaglutide Canada Approval Clears Market Entry

Aspen Semaglutide Canada gains Health Canada approval, but API supply problems could delay the generic’s commercial launch.

Read more...

Extensior South Africa Launch Targets Lower-Cost Access

The Extensior South Africa launch on 27 July, offering patients a lower-cost, authorised semaglutide treatment for type 2 diabetes.

Read more...

Ambulance Tariff Negotiations Seek Competition Exemption

Ambulance tariff negotiations could help private emergency service providers address low payments, cash-flow pressure and market contraction.

Read more...